Format
Sort by

Send to

Choose Destination

Links from Books

Items: 1 to 20 of 162

1.

Tea in chemoprevention of cancer.

Katiyar S, Mukhtar H.

Int J Oncol. 1996 Feb;8(2):221-38.

PMID:
21544351
2.

Bioavailability and catabolism of green tea flavan-3-ols in humans.

Del Rio D, Calani L, Cordero C, Salvatore S, Pellegrini N, Brighenti F.

Nutrition. 2010 Nov-Dec;26(11-12):1110-6. doi: 10.1016/j.nut.2009.09.021.

PMID:
20080030
3.

Coffee, green tea, black tea and oolong tea consumption and risk of mortality from cardiovascular disease in Japanese men and women.

Mineharu Y, Koizumi A, Wada Y, Iso H, Watanabe Y, Date C, Yamamoto A, Kikuchi S, Inaba Y, Toyoshima H, Kondo T, Tamakoshi A; JACC study Group..

J Epidemiol Community Health. 2011 Mar;65(3):230-40. doi: 10.1136/jech.2009.097311.

PMID:
19996359
4.

Green tea consumption improves endothelial function but not circulating endothelial progenitor cells in patients with chronic renal failure.

Park CS, Kim W, Woo JS, Ha SJ, Kang WY, Hwang SH, Park YW, Kim YS, Ahn YK, Jeong MH, Kim W.

Int J Cardiol. 2010 Nov 19;145(2):261-2. doi: 10.1016/j.ijcard.2009.09.471.

PMID:
19962201
5.

Genetic inactivation of ApoJ/clusterin: effects on prostate tumourigenesis and metastatic spread.

Bettuzzi S, Davalli P, Davoli S, Chayka O, Rizzi F, Belloni L, Pellacani D, Fregni G, Astancolle S, Fassan M, Corti A, Baffa R, Sala A.

Oncogene. 2009 Dec 10;28(49):4344-52. doi: 10.1038/onc.2009.286.

PMID:
19784068
6.

Green tea (Camellia sinensis) catechins and vascular function.

Moore RJ, Jackson KG, Minihane AM.

Br J Nutr. 2009 Dec;102(12):1790-802. doi: 10.1017/S0007114509991218. Review.

PMID:
19751534
7.

Polyphenon E: a new treatment for external anogenital warts.

Tatti S, Stockfleth E, Beutner KR, Tawfik H, Elsasser U, Weyrauch P, Mescheder A.

Br J Dermatol. 2010 Jan;162(1):176-84. doi: 10.1111/j.1365-2133.2009.09375.x.

PMID:
19709100
8.

Dietary phenolics: chemistry, bioavailability and effects on health.

Crozier A, Jaganath IB, Clifford MN.

Nat Prod Rep. 2009 Aug;26(8):1001-43. doi: 10.1039/b802662a. Review.

PMID:
19636448
9.

Green tea (Camellia sinensis) for the prevention of cancer.

Boehm K, Borrelli F, Ernst E, Habacher G, Hung SK, Milazzo S, Horneber M.

Cochrane Database Syst Rev. 2009 Jul 8;(3):CD005004. doi: 10.1002/14651858.CD005004.pub2. Review.

PMID:
19588362
10.

Inflammatory disease processes and interactions with nutrition.

Calder PC, Albers R, Antoine JM, Blum S, Bourdet-Sicard R, Ferns GA, Folkerts G, Friedmann PS, Frost GS, Guarner F, Løvik M, Macfarlane S, Meyer PD, M'Rabet L, Serafini M, van Eden W, van Loo J, Vas Dias W, Vidry S, Winklhofer-Roob BM, Zhao J.

Br J Nutr. 2009 May;101 Suppl 1:S1-45. doi: 10.1017/S0007114509377867. Review.

PMID:
19586558
11.

Cancer prevention by tea: animal studies, molecular mechanisms and human relevance.

Yang CS, Wang X, Lu G, Picinich SC.

Nat Rev Cancer. 2009 Jun;9(6):429-39. doi: 10.1038/nrc2641. Review.

12.

Epigallocatechin 3-gallate and green tea catechins: United they work, divided they fail.

Bode AM, Dong Z.

Cancer Prev Res (Phila). 2009 Jun;2(6):514-7. doi: 10.1158/1940-6207.CAPR-09-0083. Review. No abstract available.

13.

Weight and plasma lipid control by decaffeinated green tea.

Richard D, Kefi K, Barbe U, Poli A, Bausero P, Visioli F.

Pharmacol Res. 2009 May;59(5):351-4. doi: 10.1016/j.phrs.2009.01.015.

PMID:
19416635
14.

Milk decreases urinary excretion but not plasma pharmacokinetics of cocoa flavan-3-ol metabolites in humans.

Mullen W, Borges G, Donovan JL, Edwards CA, Serafini M, Lean ME, Crozier A.

Am J Clin Nutr. 2009 Jun;89(6):1784-91. doi: 10.3945/ajcn.2008.27339.

15.

Green tea: nature's defense against malignancies.

Butt MS, Sultan MT.

Crit Rev Food Sci Nutr. 2009 May;49(5):463-73. doi: 10.1080/10408390802145310. Review.

PMID:
19399671
16.

A thought on the biological activities of black tea.

Sharma V, Rao LJ.

Crit Rev Food Sci Nutr. 2009 May;49(5):379-404. doi: 10.1080/10408390802068066. Review.

PMID:
19399668
17.

Molecular basis for cancer chemoprevention by green tea polyphenol EGCG.

Tachibana H.

Forum Nutr. 2009;61:156-69. doi: 10.1159/000212748. Review.

PMID:
19367120
18.

Catechin prevents endothelial dysfunction in the prediabetic stage of OLETF rats by reducing vascular NADPH oxidase activity and expression.

Ihm SH, Lee JO, Kim SJ, Seung KB, Schini-Kerth VB, Chang K, Oak MH.

Atherosclerosis. 2009 Sep;206(1):47-53. doi: 10.1016/j.atherosclerosis.2009.01.036.

PMID:
19264308
19.

Molecular targets of (-)-epigallocatechin-3-gallate (EGCG): specificity and interaction with membrane lipid rafts.

Patra SK, Rizzi F, Silva A, Rugina DO, Bettuzzi S.

J Physiol Pharmacol. 2008 Dec;59 Suppl 9:217-35. Review.

20.

Molecular targets for cancer chemoprevention.

William WN Jr, Heymach JV, Kim ES, Lippman SM.

Nat Rev Drug Discov. 2009 Mar;8(3):213-25. doi: 10.1038/nrd2663. Review.

PMID:
19247304
Items per page

Supplemental Content

Support Center